(59a) Controlling the Immune Response through Controlling the Aggregation Kinetics of Engineered Peptides
AIChE Annual Meeting
2022
2022 Annual Meeting
Food, Pharmaceutical & Bioengineering Division
Cell and Tissue Engineering: Engineering the Immune Response
Monday, November 14, 2022 - 8:00am to 8:18am
In this study, we showed the control over peptide assembly, as in Aβ1-42 oligomerization, to control the immune response effect of PAIIR, as vaccine adjuvants.2 In this study, we created aggregates of the PAIIR that can assemble in different kinetics (shown as 0.002% fastest and 0.2% slowest). The aggregation kinetics affected their cell membrane rupture kinetics, thus their immunogenicity. We showed detailed characterization of the peptide aggregation, membrane damage, and cell death profiles of these aggregates on several cell lines. We used ovalbumin (OVA) as the antigen and prepared cocktails of different aggregation PAIIRs. Antibody formation in mice followed the same aggregation kinetics profile (Fig.1); the slowest aggregation provided the highest number of antibodies. In this study, we showed controlling the effects of biomaterials on the cells and overall organism, through molecular engineering principles.
[1] Hamsici, S. et al. Peptide framework for screening the effects of amino acids on assembly. Science Advances (2022)
[2] Gunay, G. et al. Peptide Aggregation Induced Immunogenic Rupture (PAIIR). BioRxiv (2022)